This article is more than 5 years old. Information may no longer be current.
VIDEO: Cyclo G6 reduces IOP without heat of traditional laser
Click Here to Manage Email Alerts
NEW ORLEANS — In a study using the Iridex Cyclo G6 system with the MicroPulse P3 probe to reduce IOP in a cohort of glaucoma patients, IOP lowering was “very much what we would expect for any incisional glaucoma procedure,” Robert J. Noecker, MD, said at Glaucoma Day preceding the American Society of Cataract and Refractive Surgery meeting.
Noecker reported his 1-year experience using the Iridex system in 45 glaucomatous eyes. Mean preoperative IOP was 28.1 mm Hg; mean postoperative IOP at 12 months was 16.4 mm Hg. Mean number of medications preoperatively was 3.2; 12 months postoperatively, it was 1.1, according to the presentation.
“When you look at studies comparing efficacy of micropulse transscleral vs. traditional transscleral, the IOP lowering is very similar,” with the difference being that there is no phthisis, chronic hypotony or inflammation associated with the micropulse technology, he said.
“In terms of cyclophotocoagulation, this is actually a very cold laser,” he said, with the relative temperature being “magnitudes less” than traditional laser, “not much above body temperature.” – by Patricia Nale, ELS
Reference:
Noecker RJ. The lighter side of cyclodestruction: MP3CPC and ECP. Presented at: American Society of Cataract and Refractive Surgery meeting; May 6-10, 2016; New Orleans.
Disclosure: Noecker reports he is a paid consultant for Iridex and Beaver-Visitec International.